New and Special Drug
Hemlibra (Emicizumab) – Hemophilia A | HongKong DengYue Medicine
Dongyinghe (Encofosbuvir) – Hepatitis C | HongKong DengYue Medicine
Cyramza (Ramucirumab) – NSCLC | HongKong DengYue Medicine
Rystiggo (Rozanolixizumab) – gMG | HongKong DengYue Medicine
Margenza (Margetuximab) – HER2 | HongKong DengYue Medicine
Bimzelx (Bimekizumab) – Psoriasis | HongKong DengYue Medicine
Xgeva (Denosumab) – GCTB | HongKong DengYue Medicine
Caprelsa (Vandetanib) – MTC | HongKong DengYue Medicine
Romlusevimab – COVID-19 | HongKong DengYue Medicine
Jinbeixin (Firsekibart) – Gouty Arthritis (GA) | HongKong DengYue Medicine
Zytiga (Abiraterone Acetate) – mCRPC/mCSPC | HongKong DengYue Medicine
Ocrevus (Ocrelizumab) – RMS/PPMS | HongKong DengYue Medicine
Valcyte (Valganciclovir) – CMV | HongKong DengYue Medicine
Mektovi (Binimetinib) – Melanoma | HongKong DengYue Medicine
Supect (Radotinib) – Ph+ CML | HongKong DengYue Medicine
Hernexeos (Zongertinib) – NSCLC | HongKong DengYue Medicine
